We’re happy to announce that our family angel program (back 80+ entrepreneurs over eight years and donate all gains to charity; details here) has invested in Alchemi. We invested last year, but the company now has emerged from stealth mode. We’re really excited to be part of what Harvard Business School graduates Anuj Chadha and Tom Mulvey are doing.

I was fortunate to have Anuj as a student a few years ago in the entrepreneurial management course that all HBS first-year students take. He was part of Section F, which I was in when I was a student. For some reason, I really clicked with that Section and still miss seeing them.

You can read more about the company here. A summary is below:

It takes over a decade and more than $2 billion to bring a new drug to market.

We founded Alchemi to change this. We’re creating a future where AI will work in tandem with scientists, accelerating drug development.

In doing so we can reduce timelines, lower drug costs, and increase access to life saving medicines.

Thank you, Anuj and Tom, for letting us invest!